|Bid||1.0000 x N/A|
|Ask||1.0400 x N/A|
|Day's range||1.0000 - 1.0500|
|52-week range||0.6600 - 1.5000|
|Beta (5Y monthly)||N/A|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||1.52|
LIVERPOOL, England, January 12, 2022--More than 100 pharmacies across Liverpool will offer patients with acute cough a 10-minute FebriDx test to enable rapid diagnoses and treatment.
MELBOURNE, Australia, November 03, 2021--Health Canada has granted Interim Order authorization for CoviDx – a rapid antigen test to help healthcare providers confirm the presence of COVID-19.
Every investor in Lumos Diagnostics Holdings Limited ( ASX:LDX ) should be aware of the most powerful shareholder...